Search Results
Nov 26, 2025, 05:00 ET AI Tops Density in Predicting Breast Cancer Risk
high-risk AI group had more than a fourfold higher cancer incidence than women in the average-risk group (5.9% vs. 1.3%). By contrast, breast density alone showed only modest separation (3.2% for dense vs. 2.7% for non-dense)."The results of this large-scale analysis demonstrate that AI risk models provide
More news about: Radiological Society of North America (RSNA)
Nov 26, 2025, 05:00 ET Department of Education's Loan Proposal Puts Nursing Workforce and Patient Care at Risk
26, 2025 /PRNewswire/ -- The American Nurses Association (ANA) is deeply concerned by the Department of Education's recent statements of "myth vs. fact" that minimize the potential adverse impact of federal loan eligibility rules under consideration by the Department.
More news about: American Nurses Association
Nov 26, 2025, 04:30 ET Singapore staat op nr. 1 in wereldwijde strijd om talent
talent te cultiveren en in verschillende sectoren in te zetten, wordt weerspiegeld in de sterke positie van de VS (9e) en Canada (14e) – ondanks de slechtere prestatie van de VS in vergelijking met 2023.Noord-Afrika en West-Azië werden aangevoerd door Israël (23e),
More news about: INSEAD
Nov 26, 2025, 03:00 ET First-Ever UHNWI Survey Reveals Greece's Luxury Real Estate Market Has Reached Mediterranean Elite Status
Mykonos (€10,800/m²) vs. Ibiza (€11,600/m²)Athens Riviera (€10,500/m²) vs. Dubai coastal (€12,600/m²)
More news about: Greece Sotheby's International Realty
Nov 26, 2025, 01:48 ET Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal
favored infliximab SC over placebo in both location groups (clinical response: 62.86% vs 41.18% in ileum-dominant and 67.80% vs 38.18% in colon-dominant; endoscopic response: 53.33% vs 19.61% in ileum-dominant and 52.54% vs 18.18% in colon dominant). When assessed at the segment level, endoscopic responses
More news about: Celltrion
Nov 26, 2025, 01:22 ET Third Quarter Financial Results: Strauss Group concludes a strong quarter with an increase of 10% in Sales to NIS 3.3 billion and an increase of 43% in Net Income to NIS 146 million
reaching NIS 302 million (12.8% margin). Sales were supported by higher volume and improved mix in 9M-2025. The lower EBIT and EBIT margin in Q3-2025 vs. Q3-2024 were mainly due to increased marketing efforts, divestment of the Ultra Fresh activity as well as one-off expenses related to quality assurance
More news about: Strauss Group Ltd.
Nov 25, 2025, 16:20 ET Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman
2024, and August 4, 2025 (the "Class Period"), charging violations of the Securities Exchange Act of 1934.The Heart of the Complaint: Inspire V's Alleged FailuresInspire Medical, known for its implantable neurostimulation technology designed to improve respiration during
More news about: Hagens Berman Sobol Shapiro LLP
Nov 25, 2025, 10:35 ET Locus Biosurfactants deliver industry leading oil production uplift in the Permian
production and economic data. Production Results Highlights +20% oil, +15% gas, and 23% lower WOR vs. control wells12× ROI within six months; payout in under one monthImproved flowback, higher IP, and sustained uplift
More news about: Locus Fermentation Solutions
Nov 25, 2025, 07:30 ET Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
observed: LEQEMBI, 17%; placebo, 9%. No increase in isolated ARIA-H was observed for LEQEMBI vs placebo.Incidence of ICHICH >1 cm in diameter was reported in 0.7% with LEQEMBI vs 0.1% with placebo. Fatal events of ICH in patients taking LEQEMBI have been observed.Risk
More news about: Eisai Inc.
Nov 25, 2025, 07:00 ET The J.M. Smucker Co. Announces Fiscal 2026 Second Quarter Results
PreviousNet sales increase vs. prior year
More news about: The J.M. Smucker Co.
Nov 25, 2025, 06:00 ET Realtor.Com®: New Homes Now Priced Closer To Existing Homes Than Ever
– an all-time high. New home reductions were most common in the South (15.9% vs 18.7% for existing) and West (16.6% vs 18.7% for existing) and less frequent in the Midwest (12.2% vs 17.1% for existing) and Northeast (7.8% vs 12.1% for existing).MethodologyRealtor.com®
More news about: Realtor.com
Nov 25, 2025, 05:00 ET Rubber Track Market worth $1.63 billion by 2032 | MarketsandMarkets™
configurations on popular compact and mid-size models, including the John Deere 325G compact track loader, Bobcat E88 and E40 mini excavators, and the Yanmar TL100VS CTL, highlighting the industry's shift toward terrain-optimized, high-performance track technologies. Overall, the zig-zag segment is becoming a key
More news about: MarketsandMarkets
Nov 25, 2025, 04:43 ET DICK'S Sporting Goods benoemt Matthew Barnes tot voorzitter van Foot Locker International
executive, verrijkt zijn nieuwe functie bij Foot Locker met bijna drie decennia ervaring in leidinggevende functies in het Verenigd Koninkrijk, Europa, de VS, China en Australië. Hij heeft een bewezen staat van dienst in het leiden van consumentgerichte bedrijven door perioden van groei en transformatie, onder
More news about: DICK'S Sporting Goods, Inc.
Nov 25, 2025, 01:00 ET Hankook Sets Momentum for the 2025 FIA World Rally Championship Finale, Rally Saudi Arabia
R213 designed to support confident performance across demanding desert sand and jagged rocky terrainGlobal spotlight on the Elfyn Evans vs. Sébastien Ogier showdown for the Drivers' Championship titleJEDDAH, Saudi Arabia, Nov.
More news about: Hankook Tire
Nov 24, 2025, 16:30 ET Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium
(98% vs 84%; 2.2% vs 0%), decreased white blood cells (82% vs 27%; 13% vs 0.6%), anemia (82% vs 28%; 1.6% vs 0%), decreased neutrophil count (80% vs 21%; 21.9% vs 2.6%), decreased lymphocyte count (53% vs 26%; 7.6% vs 1.9%), decreased platelet count (36% vs 12%; 1.9% vs 0.6%), increased ALT (48% vs 25%;
More news about: Eli Lilly and Company
Nov 24, 2025, 16:20 ET Family Experience Brand CAMP Selects Newly Launched Board as its "Gift of the Season" for 2025
with 12 original games, spanning arcade, strategy, action and more. Developed by award-winning designers from games like Manifold Garden, Plants vs. Zombies, Diner Dash and Shadows Over Camelot, games are built to be intuitive and fun for every player and for every age.Try It
More news about: Board
Nov 24, 2025, 15:50 ET AICPA, State CPA Societies Urge Department of Education to Recognize Accounting Programs as Professional Degree Programs
federal government's own projections suggest that demand for accountants will continue to outstrip demand for jobs in general through 2034 (+5% growth vs. +3%, according to the Bureau of Labor Statistics), making it even more critical that support mechanisms such as recognition and financial aid are in
More news about: AICPA
Nov 24, 2025, 12:50 ET CME Group Cryptocurrency Complex Reaches All-Time Daily Volume Record
in notional), up 82% year-over-yearQ4 ADV of 403,200 contracts ($14.2 billion in notional), up 106% vs. Q4 '24, with average OI 493,700 contracts ($35.4 billion in notional), up 117% vs. Q4 '24For more information, please visit:
More news about: CME Group
Nov 24, 2025, 12:00 ET Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting
Pirtobrutinib vs ibrutinib in treatment-naïveand relapsed/refractory CLL/SLL: Results from the first randomized Phase 3 study comparing a non-covalent
More news about: Eli Lilly and Company
Nov 24, 2025, 11:39 ET Aesthetic Fillers Market Surges to USD 8.45 Billion by 2033, Propelled by 7.2% CAGR - Verified Market Reports®
two-tier safety governance model for rapid-growth markets to reduce adverse events and protect brand trust.Design tiered product stacks (value vs premium) with clear clinical differentiation, and pilot bundled pricing with top 10 clinic groups per country.Allocate CAPEX to clinician education
More news about: Verified Market Reports
Nov 24, 2025, 10:08 ET Report: CEO Departures Are Rising, Even at Strong-Performing Companies
CEOs remained the same in 2024 and 2025 (48 women CEOs).Russell 3000: Women represent 7.7% of CEOs, slightly up from 7.6% in 2024 (230 vs. 225 CEOs).Understanding the numbers: These modest shifts mark a pause after steady gains between 2020 and 2024, when representation rose
More news about: The Conference Board
Nov 24, 2025, 09:22 ET As Local Law 97 Enforcement Strengthens, Cotocon Urges Building Owners to Plan Ahead with Precision
reliable numbers for:Annual energy use by fuel typeVerified space type breakdown2024 emissions performance vs. allowed limitsProjected 2030 caps and potential penalties"Owners cannot make capital decisions on guesswork," Carchietta said.
More news about: The Cotocon Group
Nov 24, 2025, 09:00 ET New 'Sonar' release solidifies Search Party as top platform for controlling AI visibility in 2026
before it scales through AI-generated answers.When positive sentiment surfaces, brands can amplify it so wins compound.Search Party vs. CompetitorsSonar and its brand sentiment analytics solidify Search Party as the industry's leading AI visibility platform for answer engine
More news about: Search Party
Nov 24, 2025, 07:00 ET bidadoo Achieves Record Q3, Strengthening Position as Leading Online Auction Platform
recommend bidadoo for anyone looking for a well-managed and transparent auction experience."bidadoo's Record-Breaking Third Quarter (Q3) 2025 vs. 2024 Featured:Large Growth Area: 30% Growth in Large / Strategic Account SalesConvenience:
More news about: bidadoo
Nov 24, 2025, 06:59 ET Automotive Suspension Market worth $42.43 billion by 2032 | MarketsandMarkets™
(strong premium SUV & pickup demand and regulatory pressure on vehicle & passenger safety & curb emissions), restraints (high system cost vs. ROI in non-premium segments), opportunities (integration of smart/connected suspensions with ADAS & SDVs and local manufacturing & supply chain
More news about: MarketsandMarkets